Bcl-2 accelerates the neuronal differentiation: New evidence approaching to the biofunction of Bcl-2 in the neuronal system

Brain Research

Volumn 801, Issue 1-2, 1998, Pages 59-66

  Suzuki, Atsushi ^a   Tsutomi, Yumi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Bcl 2; Neurofilament; Neuronal differentiation; Neurotoxic compound; PC12

Indexed keywords

NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; PACLITAXEL; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; NERVE CELL DIFFERENTIATION; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTO ONCOGENE; RAT;

ANIMALS; BIOPOLYMERS; CELL DIFFERENTIATION; HUMANS; MODELS, BIOLOGICAL; NERVE GROWTH FACTORS; NEUROFILAMENT PROTEINS; NEURONS; PACLITAXEL; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; STEM CELLS; TRANSFECTION;

EID: 0032504646     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00523-X     Document Type: Article

References (37)

1. Akao Y., Otsuki Y., Kataoka S., Ito Y., Tsujimoto Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum, and mitochondrial membranes. Cancer Res. 54:1994;2468-2471.
2. Allsopp T.E., Wyatt S., Paterson H.P., Davies A.M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295-307.
3. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
4. Cavaletti G., Tredici G., Braga M., Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of Taxol. Exp. Neurol. 133:1995;64-72.
5. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1996;733-736.
6. Farlie P.G., Dringen R., Ress S.M., Kannouraskis G., Bernard O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4397-4401.
7. Geisler N., Weber K. Self-assembly in Vitro of the 68,000 molecular weight component of the mammalian neurofilament triplet proteins into intermediate-sized filaments. J. Mol. Biol. 151:1981;565-571.
8. Glisson B.S., Ross W.E. DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy. Pharmacol. Ther. 32:1987;4338-4344.
9. Green L.A., Aletta J.M., Rukenstein A., Green S.H. PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol. 147:1987;207-216.
10. Hasegawa J., Kamada S., Kamiike W., Shimizu S., Imazu T., Matsuda H., Tsujimoto Y. Involvement of CPP32/Yama(-like) proteases in Fas-mediated apoptosis. Cancer Res. 56:1996;1713-1718.
11. Itoh N., Tsujimoto Y., Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:1993;621-627.
12. Jacobson M.D., Raff M.C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature. 374:1995;814-819.
13. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., Tsujimoto Y. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55:1995;354-359.
14. Kondo S., Yin D., Takeuchi J., Morimura T., Oda Y., Kikuchi H. bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow) induced by chemotherapy. Br. J. Cancer. 70:1994;421-426.
15. Mapara M.Y., Bargou R., Zugck C., Dohner H., Ustaoglu F., Jonker R.R., Krammer P.H., Dorken B. APO-I mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:1993;702-708.
16. Mesner P.W., Winters T.R., Green S.H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119:1992;1669-1680.
17. Negrini M., Silini E., Kozak C., Tsujimoto Y., Croce C.M. Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell. 49:1987;455-463.
18. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
19. Roytta M., Raine C.S. Taxol-induced neuropathy: further ultrastructure studies of nerve fibre changes in situ. J. Neurocyto. 14:1985;157-175.
20. Roytta M., Raine C.S. Taxol-induced neuropathy: chronic effects of local injection. J. Neurol. 15:1986;483-496.
21. Sato N., Hotta K., Waguri S., Nitatori T., Tohyama K., Tsujimoto Y., Uchiyama Y. Neuronal differentiation of PC12 cells as a result of prevention of cell death by bcl-2. J. Neurobiol. 25:1994;1227-1234.
22. Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signaling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature. 386:1997;728-731.
23. Shimizu S., Eguchi Y., Kamiike W., Matsuda H., Tsujimoto Y. Bcl-2 expression prevents activation of ICE protease cascade. Oncogene. 12:1996;2251-2257.
24. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Bcl-2 blocks loss of mitochondrial membrane potencial while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene. 13:1996;21-29.
25. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene. 12:1996;2045-2050.
26. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature. 374:1995;811-813.
27. Soifer D., Iqbal K., Czosnek H., De Martini J., Sturman J.A., Wisniewski H.M. The loss of neuron-specific proteins during the course of Wallerian degenaration of optic and sciatic nerve. J. Neurosci. 1:1981;461-470.
28. Suzuki A. Amyloid β-protein induces necrotic cell death mediated by ICE cascade in PC12 cells. Exp. Cell Res. 234:1997;507-511.
29. Suzuki A., Iwasaki M., Kato M., Wagai N. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp. Cell Res. 233:1997;41-47.
30. Suzuki A., Iwasaki M., Wagai N. Involvement of cytoplasmic serineproteinase and CPP32 subfamily in the molecular machinery of caspase 3 activation during Fas-mediated apoptosis. Exp. Cell. Res. 233:1997;48-55.
31. Tsujimoto Y. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell. Oncogene. 4:1989;1331-1336.
32. Tsujimoto Y., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14; 18) chromosome translocation. Science. 226:1984;1097-1099.
33. Vaux D.L., Cory S., Adams J.M. bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
34. Veis J.D., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75:1993;229-240.
35. Wang H.-G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
36. Woods C.M., Zhu J., McQueney P.A., Bollag D., Lazarides E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1:1995;506-526.
37. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.